123 related articles for article (PubMed ID: 35724673)
21. [MicroRNA-218 promotes osteosarcoma cell apoptosis by down-regulating oncogene B lymphoma mouse Moloney leukemia virus insertion region 1].
Lai GH; Huang AL; Zhao Z; Lu XH; Zu WX
Nan Fang Yi Ke Da Xue Xue Bao; 2018 May; 38(5):505-510. PubMed ID: 29891444
[TBL] [Abstract][Full Text] [Related]
22. Quercetin Enhances Cisplatin Sensitivity of Human Osteosarcoma Cells by Modulating microRNA-217-KRAS Axis.
Zhang X; Guo Q; Chen J; Chen Z
Mol Cells; 2015 Jul; 38(7):638-42. PubMed ID: 26062553
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-340-5p modulates cisplatin resistance by targeting LPAATβ in osteosarcoma.
Song L; Duan P; Gan Y; Li P; Zhao C; Xu J; Zhang Z; Zhou Q
Braz J Med Biol Res; 2017 Apr; 50(5):e6359. PubMed ID: 28443990
[TBL] [Abstract][Full Text] [Related]
24. Effect of microRNA-101 on proliferation and apoptosis of human osteosarcoma cells by targeting mTOR.
Lin S; Shao NN; Fan L; Ma XC; Pu FF; Shao ZW
J Huazhong Univ Sci Technolog Med Sci; 2014 Dec; 34(6):889-895. PubMed ID: 25480586
[TBL] [Abstract][Full Text] [Related]
25. Mevalonate pathway inhibitors affect anticancer drug-induced cell death and DNA damage response of human sarcoma cells.
Nilsson S; Huelsenbeck J; Fritz G
Cancer Lett; 2011 May; 304(1):60-9. PubMed ID: 21356574
[TBL] [Abstract][Full Text] [Related]
26. TGF-β protects osteosarcoma cells from chemotherapeutic cytotoxicity in a SDH/HIF1α dependent manner.
Xu Y; Li Y; Chen X; Xiang F; Deng Y; Li Z; Wei D
BMC Cancer; 2021 Nov; 21(1):1200. PubMed ID: 34763667
[TBL] [Abstract][Full Text] [Related]
27. Anti-ganglioside GD2 monoclonal antibody synergizes with cisplatin to induce endoplasmic reticulum-associated apoptosis in osteosarcoma cells.
Zhu W; Mao X; Wang W; Chen Y; Li D; Li H; Dou P
Pharmazie; 2018 Feb; 73(2):80-86. PubMed ID: 29442009
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-21 regulates the sensitivity to cisplatin in a human osteosarcoma cell line.
Ziyan W; Yang L
Ir J Med Sci; 2016 Feb; 185(1):85-91. PubMed ID: 25381586
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA‑22 inhibits the proliferation and migration, and increases the cisplatin sensitivity, of osteosarcoma cells.
Zhou X; Natino D; Zhai X; Gao Z; He X
Mol Med Rep; 2018 May; 17(5):7209-7217. PubMed ID: 29568877
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-17-5p regulates the growth, migration and invasion of the human osteosarcoma cells by modulating the expression of PTEN.
Ming He J; Liu PY; Wang J
J BUON; 2020; 25(2):1028-1034. PubMed ID: 32521902
[TBL] [Abstract][Full Text] [Related]
31. Investigating the Role of Quercetin in Increasing the Rate of Cisplatin-Induced Apoptosis Via the NF-κB Pathway in MG-63 Cancer Cells.
Ahmadi M; Valizadeh A; Bazavar M; Yousefi B
Drug Res (Stuttg); 2022 Sep; 72(7):385-389. PubMed ID: 35785813
[TBL] [Abstract][Full Text] [Related]
32. Establishment and Characterization of Multi-Drug Resistant p53-Negative Osteosarcoma SaOS-2 Subline.
Boichuk S; Bikinieva F; Valeeva E; Dunaev P; Vasileva M; Kopnin P; Mikheeva E; Ivoilova T; Mustafin I; Galembikova A
Diagnostics (Basel); 2023 Aug; 13(16):. PubMed ID: 37627905
[TBL] [Abstract][Full Text] [Related]
33. The modulatory effects of two bioflavonoids, quercetin and thymoquinone on the expression levels of DNA damage and repair genes in human breast, lung and prostate cancer cell lines.
Karimian A; Majidinia M; Moliani A; Alemi F; Asemi Z; Yousefi B; Fazlollahpour Naghibi A
Pathol Res Pract; 2022 Dec; 240():154143. PubMed ID: 36347210
[TBL] [Abstract][Full Text] [Related]
34. Syndecan-2 affects the basal and chemotherapy-induced apoptosis in osteosarcoma.
Orosco A; Fromigué O; Bazille C; Entz-Werle N; Levillain P; Marie PJ; Modrowski D
Cancer Res; 2007 Apr; 67(8):3708-15. PubMed ID: 17440083
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-184 Modulates Doxorubicin Resistance in Osteosarcoma Cells by Targeting BCL2L1.
Lin BC; Huang D; Yu CQ; Mou Y; Liu YH; Zhang DW; Shi FJ
Med Sci Monit; 2016 May; 22():1761-5. PubMed ID: 27222034
[TBL] [Abstract][Full Text] [Related]
36. Quercetin suppresses the proliferation and metastasis of metastatic osteosarcoma cells by inhibiting parathyroid hormone receptor 1.
Li S; Pei Y; Wang W; Liu F; Zheng K; Zhang X
Biomed Pharmacother; 2019 Jun; 114():108839. PubMed ID: 30978523
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-221 promotes cisplatin resistance in osteosarcoma cells by targeting PPP2R2A.
Yu WC; Chen HH; Qu YY; Xu CW; Yang C; Liu Y
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31221814
[TBL] [Abstract][Full Text] [Related]
38. LncRNA-SARCC sensitizes osteosarcoma to cisplatin through the miR-143-mediated glycolysis inhibition by targeting Hexokinase 2.
Wen JF; Jiang YQ; Li C; Dai XK; Wu T; Yin WZ
Cancer Biomark; 2020; 28(2):231-246. PubMed ID: 32508321
[TBL] [Abstract][Full Text] [Related]
39. P14ARF sensitizes human osteosarcoma cells to cisplatin-induced apoptosis in a p53-independent manner.
Yuan XW; Zhu XF; Huang XF; Sheng PY; He AS; Yang ZB; Deng R; Feng GK; Liao WM
Cancer Biol Ther; 2007 Jul; 6(7):1074-80. PubMed ID: 17611411
[TBL] [Abstract][Full Text] [Related]
40. GTSE1 is possibly involved in the DNA damage repair and cisplatin resistance in osteosarcoma.
Xie C; Xiang W; Shen H; Shen J
J Orthop Surg Res; 2021 Dec; 16(1):713. PubMed ID: 34876170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
